An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Completed · Has a placebo group

Conditions studied: Mild Cognitive Impairment

In brief

The purpose of the study is to collect data of patients who were randomized (assignment of study medication by chance) and treated in 3 previous studies of galantamine (CR003145, CR002014 and CR005947) for the treatment of mild cognitive impairment (isolated memory impairment). This data were not recorded during the course of these 3 previous studies.

Key facts

Study ID

NCT00297414

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

1083

Starts

2004-06-01

Expected to finish

2005-01-01

Last updated by the study team

2012-04-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients who were randomized and treated with galantamine or placebo in 3 previous studies (CR003145, CR002014, and CR005947)

You may not qualify if…

• Patients not enrolled in above referenced studies

Where it is running

• Study site — Laguna Woods, California, United States
• Study site — Northridge, California, United States
• Study site — Oceanside, California, United States
• Study site — Paramount, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — Hamden, Connecticut, United States
• Study site — Hartford, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Miami, Florida, United States
• Study site — North Miami, Florida, United States
• Study site — Oscala F, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Paducah, Kentucky, United States
• Study site — Glen Burnie, Maryland, United States
• Study site — Rockville, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Pittsfield, Massachusetts, United States
• Study site — Farmington Hills, Michigan, United States
• Study site — Kalamazoo, Michigan, United States
• Study site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.